Esberitox is a clinically studied formula that
contains a proprietary blend of two echinacea extracts
with Baptisia and Thuja. It supports a broader
range of immune functions than single-herb echinacea
products alone. Best yet, it is provided in
convenient, chewable tablets that are safe for the
entire family.
Benefits
- Supports and fortifies the immune system and enhances
the body's natural defense mechanisms.
- Doesn't interfere with commonly prescribed
medications.
Key Features
- Clinically proven and effective immune system
stimulation.
- Clinically tested, safe, and effective for children.
- Has been a top-selling immune support product in
Europe for more than 25 years.
How Does It Work?
Esberitox is a unique blend of wild indigo
root, coneflower root, and white cedar leaf that has
been widely used in Europe for decades. This
powerful combination of herbs fortifies the immune
system, helping to strengthen the body's natural defense
mechanisms.
Research has shown that the Esberitox
combination provides a broader range of activity than
any individual component alone. This additive
effect is produced via the actions and interactions of
the concentrated botanical extracts. Although the
activities of the individual components overlap in some
way, each herb is unique in how it enhances immune
function.
The following table summarizes the key benefits of
each ingredient:
Ingredients and Benefits
Echinacea purpurea and pallida
- Increases interferon production
- Stimulates B-cell and antibody production
- Increases interleukin-1 production
- Increases production of tumor necrosis factor
Wild indigo (Baptisia tinctoria)
- Increases interferon production
- Stimulates B-cell and antibody production
- Increases interleukin-1 production
White cedar leaf (Thuja occidentalis)
- Enhances T-4 helper cells and increases
interleukin-2 production
Esberitox®
- Increases chemotaxis of white blood cells
- Increases phagocytosis rate and killing capacity of
neutrophils
- Activates macrophages
- Increases phagocytosis of macrophages
Clinical Research Findings
The safe and efficacious use of Esberitox in both
children and adults has been documented in over thirty
clinical and scientific studies. Unlike Echinacea,
which has generated both negative and positive results,
studies on the Esberitox combination have yielded only
positive findings.
Immune System Support
Several studies have examined the ability of
Esberitox to quickly and effectively
enhance immune system function. The powerful
combination promotes the body's resistive functions by
stimulating the production and activity of critical
immune cells.
One randomized, double-blind, placebo-controlled,
multi-center study involving 263 adults found that
improvement was noticeable after only two days of
supplementation - three days earlier than the placebo
group. Similar benefits have been noted in
children, where safety and tolerability have been
established for those as young as two years of age.
Esberitox is especially beneficial when extra
immune system support is desired. Clinical research
has demonstrated that supplementation increased the rate
of phagocytosis by 7.4 percent, whereas the rate in the
placebo group decreased 3.2 percent. Phagocytosis
is a process through which immune cells rid the body of
waste and foreign bodies. Esberitox has also
been shown to double the level of killer cell activity
and the lymphocyte count in individuals in need of immune
support. These findings provide strong evidence of
Esberitox's ability to stimulate the immune system.
Safety
Numerous studies have been done with various dosages and
preparations of echinacea. Research indicates that
echinacea preparations are generally considered very
safe, and few adverse effects have been reported in the
literature.
However, because of the documented immune-stimulating
action of echinacea, there is potential for a theoretical
interaction in individuals for whom immune system
enhancement is contraindicated. Therefore, we have
included the following cautionary statement on the label
as a conservative measure for our consumers:
"Not recommended for individuals with autoimmune
diseases, HIV infection, progressive systemic disease, or
who are allergic to echinacea or other flowers of the
same Compositae (or Asteraceae) family."
The potential for interaction was examined at the 1999
American Herbal Products Association International
Echinacea Symposium. The conclusion drawn following
an extensive review of the literature was that these
precautionary warnings are based more on theoretical
arguments than on specific scientific data.
Conclusion
Esberitox has a long history of safe and effective
use. This unique combination of herbs possesses a
broader spectrum of activity than Echinacea alone, and
when taken initially, can dramatically enhance the
function of the immune system.
Recommendations:
Adults and children over 12 years of
age: Three tablets, three times daily.
Age 6-12 years: Two tablets, three times
daily.
Age 2-5 years: One tablet, three times daily.
Under 2 years: Consult a healthcare
practitioner.
The tablets can be swallowed, or chewed and dissolved in
the mouth.
Esberitox should be taken when extra immune
support is needed. It should not be taken on a
daily basis for an extended period.
Caution: Not recommended for individuals
with autoimmune diseases, HIV infection, progressive
systemic disease, or who are allergic to echinacea or
other flowers of the same Compositae (or Asteraceae)
family.
If pregnant, nursing, or taking prescription drugs,
consult your healthcare practitioner prior to use.
